Company intelligence / Profile preview

Sebo Pharma

Seoul, Seoul, South Korea

Ownership: Private
Employees: ~140
Development stage: Other

Overview

Sebo Pharma is a South Korean pharmaceutical company founded in 1999 that specializes in the development and manufacturing of therapeutic agents across several key medical fields. The company is particularly recognized for its expertise in respiratory medicine, offering a variety of inhaler-based treatments for asthma and chronic obstructive pulmonary disease. Beyond respiratory health, Sebo Pharma maintains a diverse portfolio including cardiovascular, central nervous system, and gastrointestinal medications. The firm focuses on both high-quality generic formulations and the development of incrementally modified drugs to improve patient compliance and efficacy.

Therapeutic areas: CardiovascularImmunologyPulmonologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Sebo Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sebo Pharma.

Explore the full profile